Contact the Editorial Desk

Editorial correspondence

Peptides For Doctors welcomes correspondence on the research record: a citation quoted inaccurately, a regulatory reference that has gone out of date, or a peer-reviewed study on Sermorelin, Tesamorelin, or CJC-1295 that should be added to the references page. Corrections that improve accuracy are the most useful messages we receive, and they are read carefully.

The most actionable notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible.

Editorial mailbox: editors@peptidesfordoctors.com

What this desk cannot do

To prevent any message going unanswered for the wrong reason, the following fall outside what this site can address. Peptides For Doctors is a literature digest, not a clinic or a vendor, so we cannot:

• Advise on, recommend, or comment on human use of any peptide discussed here.
• Suggest a dose, schedule, or route of administration for any individual.
• Diagnose a condition or judge whether a particular research finding applies to a particular person.
• Sell, source, recommend, or help locate any compound from any supplier.
• Advise athletes on anti-doping matters, given that GHRH analogs are prohibited in sport under WADA S2.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.